A recent series of stunning lapses and oversights in federal research labs working with deadly pathogens and potential bioterror agents has heightened calls for a moratorium on such research until biosafety and security can be assured.
Once thought of as shocking outliers, the continuing hepatitis outbreaks in ambulatory care settings and clinics increasingly suggest that for every cluster detected, many more infections acquired in health care are being missed due to inadequate surveillance systems and lack of public health resources to investigate individual cases.
In light of continuing outbreaks of hepatitis in ambulatory and long-term care, the Centers for Disease Control and Prevention is considering recommending hepatitis B virus vaccination for diabetic residents of nursing homes.
